trending Market Intelligence /marketintelligence/en/news-insights/trending/_lGnZaI0v2hUeTml8-_SRw2 content esgSubNav
In This List

Eyegate Pharmaceuticals CFO resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Eyegate Pharmaceuticals CFO resigns

Ryan Brenneman is no longer Eyegate Pharmaceuticals Inc.'s CFO and principal financial and accounting officer.

Brenneman resigned from the positions, prompting company President and CEO Stephen From to assume the role of principal financial and accounting officer.